Breast cancer metastasis in obesity: extracellular vesicles as drivers
Endocrine-Related Cancer · 2026
DOI: 10.1530/erc-25-0312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Isadora Ramos-Andrade und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular & Molecular Pharmacology, IBRAG, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Extracellular Vesicles, Breast Neoplasms, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Graphical Abstract Abstract Obesity, a significant risk factor for breast cancer, contributes to tumor progression by releasing proinflammatory adipokines through extracellular vesicles (EVs) secreted by adipose tissue (AT). These EVs, which are small membrane vesicles, have the potential to modulate tumor cell behavior, yet the mechanisms underlying this communication remain largely unclear. This study investigates how EVs derived from obese AT influence malignancy-related processes in MCF-7 breast cancer cells. To assess the effects of obese AT-EVs on MCF-7 cells, EVs were isolated from the AT secretome obtained from obese and lean individuals (control group). MCF-7 cells were stimulated with these EVs, and subsequent analyses were performed to assess changes in cellular functions, epithelial marker expression, and signaling pathways. Obese AT-derived EVs exhibited significantly elevated levels of TGF-β, leading to activation of the TGF-β/SMAD signaling pathway. This activation resulted in reduced E-cadherin expression and enhanced migration and invasiveness of MCF-7 cells. Additionally, these EVs were enriched in fatty acids, which fueled the tumor cells via fatty acid oxidation (FAO), further contributing to their migratory capacity. This study identifies TGF-β signaling and FAO as central mechanisms by which obese adipose tissue-derived EVs promote a metastatic phenotype in breast cancer cells. These findings provide insight into the molecular crosstalk between obesity and breast cancer and highlight potential targets for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular & Molecular Pharmacology, IBRAG, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Redox Biology Laboratory, Programa de Farmacologia e Inflamação, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Laboratory of Inflammation and Metabolism, Department of Cellular and Molecular Biology, Universidade Federal Fluminense, Niterói, RJ, Brazil.
- Brazilian Doping Control Laboratory, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Obesity Unit, Multiuser Clinical Research Center (CePEM), Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
ORCID-Profile: Isadora Ramos-Andrade
Zitieren
APA
Ramos-Andrade, I., Amorim, C. S., Botelho, L. G. X., Franco, V. A., da Costa Nunes, I. K., Kraemer-Aguiar, L. G., Forte, Y., Atella, G. C., Moraes, J. A., Barja-Fidalgo, C., & Renovato-Martins, M. (2026). Breast cancer metastasis in obesity: extracellular vesicles as drivers. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0312
Vancouver
Ramos-Andrade I, Amorim CS, Botelho LGX, Franco VA, da Costa Nunes IK, Kraemer-Aguiar LG, et al. Breast cancer metastasis in obesity: extracellular vesicles as drivers. Endocrine-Related Cancer. 2026. doi:10.1530/erc-25-0312
BibTeX
@article{RamosAndrade2026,
author = {Ramos-Andrade, Isadora and Amorim, Carolinne Souza and Botelho, Luiz Gabriel Xavier and Franco, Victor Aguiar and da Costa Nunes, Isabelle Karine and Kraemer-Aguiar, Luiz Guilherme and Forte, Yasmin and Atella, Georgia C and Moraes, João Alfredo and Barja-Fidalgo, Christina and Renovato-Martins, Mariana},
title = {Breast cancer metastasis in obesity: extracellular vesicles as drivers},
journal = {Endocrine-Related Cancer},
year = {2026},
doi = {10.1530/erc-25-0312}
}
EUVIMED